GAO recommends CMS improve nursing home oversight

Apr 16, 2019 - 02:07 PM
gao-study

The Centers for Medicare & Medicaid Services should evaluate state survey agency processes to ensure that all states are meeting federal requirements for investigating complaints and incidents alleging abuse in nursing homes, the Government Accountability Office said in a report issued yesterday. While investigating nursing home oversight in five selected states, GAO said it found that the Oregon survey agency was not investigating all abuse complaints and facility-reported incidents as required by federal law. In a blog post yesterday, CMS Administrator Seema Verma explained how the federal agency is revising its oversight of state survey agencies. Among other actions, she noted that the agency recently released new guidance to help surveyors apply its “immediate jeopardy” standards more consistently nationwide.

Related News Articles

Headline
CDC issues advisory to healthcare providers on cyclosporiasis cases
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…
Headline
Cyclosporiasis continues to spread across country
The Centers for Disease Control and Prevention has reported 843 cases of cyclosporiasis across 31 states, with 86 people hospitalized. State health departments…
Headline
FDA issues alert for certain Medline convenience kits 
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
FDA recalls certain first aid kits with TRUE METRIX blood glucose devices 
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
AHA podcast discusses hantavirus, Ebola outbreaks and hospital readiness 
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…